Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Research

Patient-reported outcome measures in functional dyspepsia: a systematic review and COSMIN analysis

Authors: Xinai Wang, Yan Fei, Wenjing Li, Hao Liu, Hongling Xiao, Yaxuan Wu, Chenqi Wang

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Functional dyspepsia (FD) as a type of disorders of brain-gut interaction (DBGI), patient self-reporting of its symptoms becomes an important component of clinical outcome assessment. We performed a systematic review using Consensus Based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines to identify the best available patient-reported outcome measure (PROM) of FD.

Methods

The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We searched four databases with no date limit, looking for previously confirmed PROMs for evaluating FD symptoms. An overall rating was then assigned based upon COSMIN guidelines, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to assess the level of evidence for psychometric properties of included PROMs.

Results

Thirty articles covering outcome indicators of 24 patient reports were included. The Leuven Postprandial Distress Scale (LPDS) showed adequate content validity and moderate quality evidence of adequate internal consistency to generate an A recommendation.

Conclusion

LPDS is currently the most recommended PROM for patient self-reported FD symptoms. However, it fails to assess two important areas of cross-cultural validity/ measurement invariance and measurement error. Future research can be continuously improved on this basis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Drossman DA, Tack J, Ford AC, et al. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140-1171.e1.PubMedCrossRef Drossman DA, Tack J, Ford AC, et al. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140-1171.e1.PubMedCrossRef
2.
go back to reference Wauters L, Dickman R, Drug V, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterology J. 2021;9(3):307–31.CrossRef Wauters L, Dickman R, Drug V, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterology J. 2021;9(3):307–31.CrossRef
3.
go back to reference Taylor F, Reasner DS, Carson RT, et al. Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: a preliminary conceptual model and an evaluation of the adequacy of existing instruments. Patient. 2016;9(5):409–18.PubMedPubMedCentralCrossRef Taylor F, Reasner DS, Carson RT, et al. Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: a preliminary conceptual model and an evaluation of the adequacy of existing instruments. Patient. 2016;9(5):409–18.PubMedPubMedCentralCrossRef
4.
5.
go back to reference Mahadeva S, Ford AC. Clinical and epidemiological differences in functional dyspepsia between the East and the West. Neurogastroenterol Motil. 2016;28(2):167–74.PubMedCrossRef Mahadeva S, Ford AC. Clinical and epidemiological differences in functional dyspepsia between the East and the West. Neurogastroenterol Motil. 2016;28(2):167–74.PubMedCrossRef
6.
go back to reference Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3(4):252–62.PubMedCrossRef Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3(4):252–62.PubMedCrossRef
7.
go back to reference Gubatan J, Zikos T, Spear Bishop E, et al. Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic[J]. Neurogastroenterol Motil. 2022;34(4):e14243. Gubatan J, Zikos T, Spear Bishop E, et al. Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic[J]. Neurogastroenterol Motil. 2022;34(4):e14243.
8.
go back to reference Sayuk GS, Gyawali CP. Functional dyspepsia: diagnostic and therapeutic approaches. Drugs. 2020;80(13):1319–36.PubMedCrossRef Sayuk GS, Gyawali CP. Functional dyspepsia: diagnostic and therapeutic approaches. Drugs. 2020;80(13):1319–36.PubMedCrossRef
9.
go back to reference Ford AC, Moayyedi P, Black CJ, et al. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther. 2021;53(1):8–21.PubMedCrossRef Ford AC, Moayyedi P, Black CJ, et al. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther. 2021;53(1):8–21.PubMedCrossRef
10.
go back to reference Madisch A, Andresen V, Enck P, et al. The diagnosis and treatment of functional dyspepsia. Dtsch Arztebl Int. 2018;115(13):222–32.PubMedPubMedCentral Madisch A, Andresen V, Enck P, et al. The diagnosis and treatment of functional dyspepsia. Dtsch Arztebl Int. 2018;115(13):222–32.PubMedPubMedCentral
11.
go back to reference Masuy I, Van Oudenhove L, Tack J. Review article: treatment options for functional dyspepsia. Aliment Pharmacol Ther. 2019;49(9):1134–72.PubMedCrossRef Masuy I, Van Oudenhove L, Tack J. Review article: treatment options for functional dyspepsia. Aliment Pharmacol Ther. 2019;49(9):1134–72.PubMedCrossRef
12.
13.
go back to reference Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2020;69(3):591–600.PubMedCrossRef Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2020;69(3):591–600.PubMedCrossRef
14.
go back to reference Guidance for industry. patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.CrossRef Guidance for industry. patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.CrossRef
15.
go back to reference Smeets FGM, Masclee AAM, Conchillo JM, et al. Systematic review: disease‐specific instruments to assess gastrointestinal symptoms in functional dyspepsia[J]. Neurogastroenterol Motil. 2018;30(8):e13327. Smeets FGM, Masclee AAM, Conchillo JM, et al. Systematic review: disease‐specific instruments to assess gastrointestinal symptoms in functional dyspepsia[J]. Neurogastroenterol Motil. 2018;30(8):e13327.
16.
go back to reference Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures[J]. Qual Life Res. 2018;27(5):1147–57.PubMedPubMedCentralCrossRef Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures[J]. Qual Life Res. 2018;27(5):1147–57.PubMedPubMedCentralCrossRef
17.
go back to reference Alhazzani W, Guyatt G. An overview of the GRADE approach and a peek at the future. Med J Aust. 2018;209(7):291–2.PubMedCrossRef Alhazzani W, Guyatt G. An overview of the GRADE approach and a peek at the future. Med J Aust. 2018;209(7):291–2.PubMedCrossRef
18.
go back to reference Mokkink LB, De Vet HCW, Prinsen CAC, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res. 2018;27(5):1171–9.PubMedCrossRef Mokkink LB, De Vet HCW, Prinsen CAC, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res. 2018;27(5):1171–9.PubMedCrossRef
19.
go back to reference Terwee CB, Bot SD, De Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.PubMedCrossRef Terwee CB, Bot SD, De Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.PubMedCrossRef
20.
go back to reference Svedlund J, Sjödin I, Dotevall G. GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–34.PubMedCrossRef Svedlund J, Sjödin I, Dotevall G. GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–34.PubMedCrossRef
21.
go back to reference Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country study. Health Qual Life Outcomes. 2008;6:12.PubMedPubMedCentralCrossRef Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country study. Health Qual Life Outcomes. 2008;6:12.PubMedPubMedCentralCrossRef
22.
go back to reference El-Omar EM, Banerjee S, Wirz A, et al. The glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996;8(10):967–71.PubMedCrossRef El-Omar EM, Banerjee S, Wirz A, et al. The glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia. Eur J Gastroenterol Hepatol. 1996;8(10):967–71.PubMedCrossRef
23.
go back to reference Garratt AM, Ruta DA, Russell I, et al. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol. 1996;49(5):565–71.PubMedCrossRef Garratt AM, Ruta DA, Russell I, et al. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms. J Clin Epidemiol. 1996;49(5):565–71.PubMedCrossRef
24.
go back to reference Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Am J Gastroenterol. 1998;12(12):1257–62. Moayyedi P, Duffett S, Braunholtz D, et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Am J Gastroenterol. 1998;12(12):1257–62.
25.
go back to reference Shaw M, Talley NJ, Adlis S, et al. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998;12(11):1067–78.PubMedCrossRef Shaw M, Talley NJ, Adlis S, et al. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998;12(11):1067–78.PubMedCrossRef
26.
go back to reference Shaw MJ, Beebe TJ, Adlis SA, et al. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001;15(7):981–7.PubMedCrossRef Shaw MJ, Beebe TJ, Adlis SA, et al. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001;15(7):981–7.PubMedCrossRef
27.
go back to reference Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13(2):225–35.PubMedCrossRef Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13(2):225–35.PubMedCrossRef
28.
go back to reference Leidy NK, Farup C, Rentz AM, et al. Patient-based assessment in dyspepsia - Development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci. 2000;45(6):1172–9.PubMedCrossRef Leidy NK, Farup C, Rentz AM, et al. Patient-based assessment in dyspepsia - Development and validation of Dyspepsia Symptom Severity Index (DSSI). Dig Dis Sci. 2000;45(6):1172–9.PubMedCrossRef
29.
go back to reference Rabeneck L, Cook KF, Wristers K, et al. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54(8):755–65.PubMedCrossRef Rabeneck L, Cook KF, Wristers K, et al. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54(8):755–65.PubMedCrossRef
30.
go back to reference Goldman J, Conrad DF, Ley C, et al. Validation of Spanish Language Dyspepsia Questionnaire. Dig Dis Sci. 2002;47(3):624–40.PubMedCrossRef Goldman J, Conrad DF, Ley C, et al. Validation of Spanish Language Dyspepsia Questionnaire. Dig Dis Sci. 2002;47(3):624–40.PubMedCrossRef
31.
go back to reference Hu WHC, Lam KF, Wong YH, et al. The Hong Kong index of dyspepsia: A validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol (Australia). 2002;17(5):545–51.CrossRef Hu WHC, Lam KF, Wong YH, et al. The Hong Kong index of dyspepsia: A validated symptom severity questionnaire for patients with dyspepsia. J Gastroenterol Hepatol (Australia). 2002;17(5):545–51.CrossRef
32.
go back to reference Sander GB, Mazzoleni LE, Francesconi CFM, et al. Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: The Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Dig Dis Sci. 2004;49(11–12):1822–9.PubMedCrossRef Sander GB, Mazzoleni LE, Francesconi CFM, et al. Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: The Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Dig Dis Sci. 2004;49(11–12):1822–9.PubMedCrossRef
33.
go back to reference Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13(10):1737–49.PubMedCrossRef Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13(10):1737–49.PubMedCrossRef
34.
go back to reference Revicki DA, Rentz AM, Tack J, et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol. 2004;2(9):769–77.PubMedCrossRef Revicki DA, Rentz AM, Tack J, et al. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol. 2004;2(9):769–77.PubMedCrossRef
35.
go back to reference De Luca L, Zagari RM, Pozzato P, et al. Measuring dyspepsia: A new severity index validated in Bologna. Dig Liver Dis. 2004;36(12):806–10.PubMedCrossRef De Luca L, Zagari RM, Pozzato P, et al. Measuring dyspepsia: A new severity index validated in Bologna. Dig Liver Dis. 2004;36(12):806–10.PubMedCrossRef
36.
go back to reference Adam B, Liebregts T, Saadat-Gilani K, et al. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005;22(4):357–63.PubMedCrossRef Adam B, Liebregts T, Saadat-Gilani K, et al. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005;22(4):357–63.PubMedCrossRef
37.
go back to reference Veldhuyzen Van Zanten SJ, Chiba N, Armstrong D, et al. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006;23(4):521–9.PubMedCrossRef Veldhuyzen Van Zanten SJ, Chiba N, Armstrong D, et al. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ther. 2006;23(4):521–9.PubMedCrossRef
38.
go back to reference Fraser A, Delaney BC, Ford AC, et al. The Short-Form Leeds Dyspepsia Questionnaire validation study. Aliment Pharmacol Ther. 2007;25(4):477–86.PubMedCrossRef Fraser A, Delaney BC, Ford AC, et al. The Short-Form Leeds Dyspepsia Questionnaire validation study. Aliment Pharmacol Ther. 2007;25(4):477–86.PubMedCrossRef
39.
go back to reference Crowell MD, Umar SB, Lacy BE, et al. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015;60(8):2270–9.PubMedCrossRef Crowell MD, Umar SB, Lacy BE, et al. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci. 2015;60(8):2270–9.PubMedCrossRef
40.
go back to reference Carbone F, Vandenberghe A, Holvoet L, et al. Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome. Aliment Pharmacol Ther. 2016;44(9):989–1001.PubMedCrossRef Carbone F, Vandenberghe A, Holvoet L, et al. Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome. Aliment Pharmacol Ther. 2016;44(9):989–1001.PubMedCrossRef
41.
go back to reference Carbone F, Holvoet L, Vandenberghe A, et al. Functional dyspepsia: outcome of focus groups for the development of a questionnaire for symptom assessment in patients suffering from postprandial distress syndrome (PDS). Neurogastroenterol Motil. 2014;26(9):1266–74.PubMedCrossRef Carbone F, Holvoet L, Vandenberghe A, et al. Functional dyspepsia: outcome of focus groups for the development of a questionnaire for symptom assessment in patients suffering from postprandial distress syndrome (PDS). Neurogastroenterol Motil. 2014;26(9):1266–74.PubMedCrossRef
42.
go back to reference Taylor F, Higgins S, Carson RT, et al. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD). Am J Gastroenterol. 2018;113(1):39–48.PubMedCrossRef Taylor F, Higgins S, Carson RT, et al. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD). Am J Gastroenterol. 2018;113(1):39–48.PubMedCrossRef
43.
go back to reference Shi X, Luo H, Wang X, et al. Functional dyspepsia symptom diary is correlated with other questionnaires and associated with severity in patients with functional dyspepsia: a multicenter, prospective observational study. J Gastroenterol Hepatol. 2022;37:1298–306.PubMedCrossRef Shi X, Luo H, Wang X, et al. Functional dyspepsia symptom diary is correlated with other questionnaires and associated with severity in patients with functional dyspepsia: a multicenter, prospective observational study. J Gastroenterol Hepatol. 2022;37:1298–306.PubMedCrossRef
44.
go back to reference Koloski NA, Jones M, Hammer J, et al. The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. Dig Dis Sci. 2017;62(8):1913–22.PubMedCrossRef Koloski NA, Jones M, Hammer J, et al. The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting. Dig Dis Sci. 2017;62(8):1913–22.PubMedCrossRef
45.
go back to reference Smeets FGM, Keszthelyi D, Vork L, et al. Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method[J]. Neurogastroenterol Motil. 2019;31(2):e13496.PubMedCrossRef Smeets FGM, Keszthelyi D, Vork L, et al. Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method[J]. Neurogastroenterol Motil. 2019;31(2):e13496.PubMedCrossRef
46.
go back to reference Klaassen T, Smeets FGM, Vork L, et al. Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia[J]. Neurogastroenterol Motil. 2021;33(9):e14136.PubMedPubMedCentralCrossRef Klaassen T, Smeets FGM, Vork L, et al. Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia[J]. Neurogastroenterol Motil. 2021;33(9):e14136.PubMedPubMedCentralCrossRef
47.
go back to reference Chan Y, Cheong PK, Fang FF, et al. A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI-Checklist. J Gastroenterol Hepatol. 2020;35(7):1130–5.PubMedCrossRef Chan Y, Cheong PK, Fang FF, et al. A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI-Checklist. J Gastroenterol Hepatol. 2020;35(7):1130–5.PubMedCrossRef
48.
go back to reference Xiao M, Ying J, Zhao Y, et al. Developing a Scale for the Evaluation of People With Post-prandial Distress Syndrome. Front Public Health. 2021;9:695809.PubMedPubMedCentralCrossRef Xiao M, Ying J, Zhao Y, et al. Developing a Scale for the Evaluation of People With Post-prandial Distress Syndrome. Front Public Health. 2021;9:695809.PubMedPubMedCentralCrossRef
49.
go back to reference Jung K, Jung H-K, Kwon JG, et al. Development and Validity Assessment of a Self-evaluation Questionnaire for Functional Dyspepsia: A Multicenter Prospective Study in Korea. J Neurogastroenterol Motil. 2022;28(1):111–20.PubMedPubMedCentralCrossRef Jung K, Jung H-K, Kwon JG, et al. Development and Validity Assessment of a Self-evaluation Questionnaire for Functional Dyspepsia: A Multicenter Prospective Study in Korea. J Neurogastroenterol Motil. 2022;28(1):111–20.PubMedPubMedCentralCrossRef
50.
go back to reference Jones M, Talley NJ. Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia. Am J Gastroenterol. 2009;104(6):1483–8.PubMedCrossRef Jones M, Talley NJ. Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia. Am J Gastroenterol. 2009;104(6):1483–8.PubMedCrossRef
51.
go back to reference Jones MP, Sato YA, Talley NJ. The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia. Eur J Gastroenterol Hepatol. 2019;31(3):329–33.PubMedCrossRef Jones MP, Sato YA, Talley NJ. The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia. Eur J Gastroenterol Hepatol. 2019;31(3):329–33.PubMedCrossRef
52.
go back to reference Mahadeva S, Wee H-L, Goh K-L, et al. Quality of life in South East Asian patients who consult for dyspepsia: Validation of the short form Nepean Dyspepsia Index[J]. Health and Quality of Life Outcomes. 2009;7:45.PubMedPubMedCentralCrossRef Mahadeva S, Wee H-L, Goh K-L, et al. Quality of life in South East Asian patients who consult for dyspepsia: Validation of the short form Nepean Dyspepsia Index[J]. Health and Quality of Life Outcomes. 2009;7:45.PubMedPubMedCentralCrossRef
53.
go back to reference Ioannidis JP, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–75.PubMedPubMedCentralCrossRef Ioannidis JP, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–75.PubMedPubMedCentralCrossRef
54.
go back to reference Bastiaansen JA, Meurs M, Stelwagen R, et al. Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i). BMC Psychiatry. 2018;18(1):276.PubMedPubMedCentralCrossRef Bastiaansen JA, Meurs M, Stelwagen R, et al. Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i). BMC Psychiatry. 2018;18(1):276.PubMedPubMedCentralCrossRef
55.
go back to reference Riese H, Von Klipstein L, Schoevers RA, et al. Personalized ESM monitoring and feedback to support psychological treatment for depression: a pragmatic randomized controlled trial (Therap-i). BMC Psychiatry. 2021;21(1):143.PubMedPubMedCentralCrossRef Riese H, Von Klipstein L, Schoevers RA, et al. Personalized ESM monitoring and feedback to support psychological treatment for depression: a pragmatic randomized controlled trial (Therap-i). BMC Psychiatry. 2021;21(1):143.PubMedPubMedCentralCrossRef
56.
go back to reference Van Os J, Verhagen S, Marsman A, et al. The experience sampling method as an mHealth tool to support self-monitoring, self-insight, and personalized health care in clinical practice. Depress Anxiety. 2017;34(6):481–93.PubMedCrossRef Van Os J, Verhagen S, Marsman A, et al. The experience sampling method as an mHealth tool to support self-monitoring, self-insight, and personalized health care in clinical practice. Depress Anxiety. 2017;34(6):481–93.PubMedCrossRef
57.
go back to reference Tack J, Carbone F, Holvoet L, et al. The use of pictograms improves symptom evaluation by patients with functional dyspepsia. Aliment Pharmacol Ther. 2014;40(5):523–30.PubMedCrossRef Tack J, Carbone F, Holvoet L, et al. The use of pictograms improves symptom evaluation by patients with functional dyspepsia. Aliment Pharmacol Ther. 2014;40(5):523–30.PubMedCrossRef
Metadata
Title
Patient-reported outcome measures in functional dyspepsia: a systematic review and COSMIN analysis
Authors
Xinai Wang
Yan Fei
Wenjing Li
Hao Liu
Hongling Xiao
Yaxuan Wu
Chenqi Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02935-9

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.